EKEfsun Kolatan

Efsun Kolatan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Efsun Kolatan has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Potential Therapeutic Synergy of Thymoquinone and Nivolumab in Experimental Models of Renal Cancer

    by Ahmet Dirican, Özde Elif Gökbayrak, Aylin Erol, Tekincan Çağrı Aktaş, Hatice Efsun Kolatan, Efe Özgür Serinan, Zekiye Altun, Işıl Somalı, Osman Yılmaz, Safiye Aktaş

    Objective: We investigated the effects of Thymoquinone in combination with Nivolumab on experimental renal cell cancer models. Thymoquinone, a bioactive component extracted from Nigella sativa seeds, exhibits anti inflammatory, antioxidant, and anti-tumor properties against various cancers. Material and Methods: The effects of Thymoquinone and Nivolumab were analyzed using the Renca cell line with 3 (4,5-dimetiltiyazol-. 2-yl)-2.5- difeniltetrazolium-bromure and Annexin V + propidium iodure assays. Renca cells were subcutaneously injected into 8-week-old male C57BL/6 mice. Groups were designed as control, Thymoquinone, Nivolumab, Thymoquinone+Nivolumab. Tumor tissues were analyzed for apoptosis/necrosis rates, expression of immunomarkers, and ribonucleic acid expression at a significance level of p

  • Open Access

    SİSPLATİNE BAĞLI OTOTOKSİSİTEDE DARBEPOETİNİN KORUYUCU ROLÜ

    by Asuman Feda Bayrak, Yuksel Olgun, Hande Evi̇n Eski̇cİoĞlu, Selen Kum Özşengezer, Efe Özgür Seri̇nAn, Hatice Efsun Kolatan, Hasan Oğuz Çeti̇nAyak, Günay Kirkim, Safiye Aktaş, Osman Yilmaz, et al.

    Amaç: Darbepoetin-alfa (DPO) uygulamasının sisplatine bağlı ototoksik etkiyi önleyici rolü olup olmadığının in-vivo olarak değerlendirilmesi amaçlandı. Materyal metod: Çalışmada 28 adet wistar albino rat kullanılarak 4 grup oluşturuldu. Grup 1 (intraperitoneal) IP salin verilen kontrol grubu, Grup 2 sisplatin (16mg/kg IP tek doz), Grup 3 DPO (25 μg/kg IP), Grup 4 sisplatin verilmeden 24 saat önce ve verildikten yarım saat sonra 25 μg/kg tek doz IP DPO uygulanan grup. Ratlara ajan uygulamalarından önce ve deneyin 7. gününde distorsiyon ürünü otoakustik emisyon (DPOAE) ve işitsel uyarılmış beyin sapı potansiyelleri (ABR) yapıldı. İşitme ölçümleri sonrasında ratlar sakrifiye edildi. Apoptotik hücre ölümü kulak dokusunda kaspaz-3, -8, -9 ve Nrf2 ve Hem oksijenaz-1 (HO-1), NQQ1, Glutatyon (GST) gibi Nrf2 ilişkili antioksidan ve iNOS, nNOS ekspresyon düzeyleri immünohistokimyasal yöntemle çalışıldı. Serum glutatyon (GSH) ve anti-inflamatuar TNF-α ve IL-1 protein düzeyleri ELISA kitleri kullanılarak belirlendi. Bulgular: Sisplatin uygulaması ile işitme ölçümlerinde kontrole göre ototoksik etkileri gösteren tüm frekanslarda işitme kaybı saptandı. İmmunohistokimyasal doku düzeyinde gerçekleştirilen incelemelerde sisplatin uygulanan grupta iç kulakta strüktürel değişiklikler, beyin ve sinir dokularında nekroz ve nekroptoz saptandı. Darbepoetinin sisplatinin ortaya çıkardığı iç kulak ve beyin hasarlarını önleyici etkileri hem apoptotik protein ekspresyonları hem de oksidatif stres ile ilişkili belirteçler olan Nrf-2 ve ilişkili HO-1, NQO1, iNOS ve nNOS, GST ve anti-inflamatuar proteinleri üzerinden saptandı. Sonuç: Bu çalışmada sisplatinin oluşturduğu ototoksisitede DPO’in koruyucu etkileri apoptozun azaltılması, antioksidan Nrf-2 ve hedef proteinler ve glutatyon düzeylerinin artışı yanında anti-inflamatuar proteinler üzerinden geliştiği gösterilmiştir.

  • Open Access

    Effect of Korean Red Ginseng on Noise-Induced Hearing Loss

    by Serpil Mungan Durankaya, Yüksel Olgun, Safiye Aktaş, Hande Evin Eskicioğlu, Selhan Gürkan, Zekiye Altun, Başak Mutlu, Efsun Kolatan, Ersoy Doğan, Osman Yılmaz, et al.

    Noise-induced hearing loss (NIHL) is one of the most important problems affecting both social and professional life of patients. There is no treatment method considered to be successful on the hearing loss that has become a permanent nature. Aim of this study is to evaluate protective effect of Korean Red Ginseng (KRG) against NIHL in an animal model. Twenty-eight rats were separated into four groups [control saline (group I), control KRG (group II), saline + noise (group III), KRG + noise (group IV)]. Rats in the saline and KRG groups were fed via oral gavage with a dose of 200 mg/kg/day throughout for 10 days. Fourteen rats (group III and IV) were exposed to 4 kHz octave band noise at 120 dB SPL for 5 hours. Hearing levels of rats were evaluated by distortion product otoacoustic emissions (DPOAE) and auditory brainstem responses (ABR) at 4, 8, 12, 16 and 32 kHz frequencies prior to and on days 1, 7 and 10 after the noise exposure. Rats were sacrificed on 10th day, after the last audiological test. Cochlea and spiral ganglion tissues were evaluated by light microscopy. Audiological and histological results demonstrated that after noise the group IV showed better results than group III. In the noise exposed groups, the most prominent damage was seen at the 8 kHz frequency region than other regions. After the noise exposure, DPOAE responses were lost in 1st, 7th and 10th measurements in both group III and IV. Thus, we were not able to perform any statistical analyses for DPOAE results. Our findings suggest that KRG seems to be an efficient agent against NIHL. There is need for additional research to find out about the mechanisms of KRG’s protective effect.


  • The Effect of Doxycycline on Glomerulosclerosis in 5/6 Renal Ablation Nephropathy

    by Devrim Kahraman, Ali Çelik, Funda Sağlam, Osman Yılmaz, Efsun Kolatan, Zahide Çavdar, Sulen Sarıoğlu

  • Radiolabeling, In Vitro Cell Uptake, and In Vivo Photodynamic Therapy Potential of Targeted Mesoporous Silica Nanoparticles Containing Zinc Phthalocyanine

    by Ozge Er, Ayca Tuncel, Kasim Ocakoglu, Mine Ince, Efsun Hatice Kolatan, Osman Yilmaz, Safiye Aktaş, Fatma Yurt

    Photodynamic therapy (PDT) is a non-invasive therapy based on the photodynamic effect. In this study, we sought to determine intracellular uptake and in vivo photodynamic therapy potential of Zn phthalocyanine-loaded mesoporous silica nanoparticles(MSNP5) against pancreatic cancer cells.MSNP5were labeledwith 131I, the radiolabeling efficiencywas found to 95.5±1.2% in pH 9 and 60 minutes reaction time. Besides, the highest intracellular uptake yields of 131I-MSNP5 nanoparticles in MIA PaCa-2, AsPC-1, and PANC-1 cells were determined as 43.9±3.8%, 41.8±0.2%, and 37.9±1.3%, respectively at 24 hours incubation time. In vivo, PDT studies were performed with subcutaneous xenograft cancer model nude mice (AsPC-1 pancreatic cancer cells). For photodynamic therapy, 685 nm red laser light 100 J/cm2 light dose using and 5-20 µM ZnPc containing MSNP5 concentrations were applied. Histopathological studies revealed that the ratio of necrosis in tumor tissue was higher in the treatment group than the control groups.


  • Effects of atorvastatin on development of peritoneal fibrosis in rats on peritoneal dialysis

    by Yavuz Yeniçerioglu, Özlem Üzelce, Harun Akar, Efsun Kolatan, Osman Yilmaz, Çigdem Yenisey, Sulen Sarioglu, Ibrahim Meteoglu

    Rational: Peritoneal sclerosis is one of the important complications of long-term peritoneal dialysis (PD). In this study, efficacy of atorvastatin on peritoneal histology and functions in non-uremic rats on PD was tested. Objectives: Twenty-two non-uremic Wistar albino rats were randomized into three groups: Sham (intraperitoneal saline), peritoneal dialysis (PD, intraperitoneal 3.86% dextrose containing PD solution), and treatment (TX, intraperitoneal 3.86% dextrose containing PD solution plus atorvastatin added into drinking water). At the end of a 4-week period, 1 h peritoneal equilibration test was performed. Serum lipids and certain cytokines, mediators, markers, and antioxidant enzyme activities in serum and dialysate were studied. Peritoneal thickness was measured and peritoneal inflammation, fibrosis, and vascular proliferation were scored in histological sections. Main findings: In histological examinations, inflammation, fibrosis, and vascular proliferation were significantly more frequent in PD group than Sham group and it seemed to decrease significantly when atorvastatin was used in conjunction with PD. Additionally, peritoneum was significantly thicker in PD group when compared to that of Sham and TX groups. Serum parameters did not significantly differ between groups. On the other hand, dialysate glutathione reductase (GR) activity and TGF-β were significantly lower in TX group than that of the PD group, whereas dialysate IL-6 level was higher in TX group. Principal conclusions: In our study, atorvastatin use appeared to diminish structural changes in peritoneum. Decreased expression of TGF-β in dialysate may be one of the possible underlying mechanisms.


  • Protective Effects of Topiramate against Hyperoxic Brain Injury in the Developing Brain

    by S. H. Kurul, U. Yiş, A. Kumral, K. Tuğyan, S. Cilaker, E. Kolatan, O. Yılmaz, Ş. Genç

    Recent studies have shown that exposure to hyperoxia in infant rats leads to extensive apoptotic degeneration in the cortex and white matter of the developing brain. Besides its antiepileptic effects, topiramate exerts neuroprotective effects in animal models of stroke, hypoxia ischemia, excitotoxic insults, and status epilepticus. In the present study, we investigated the effects of topiramate against hyperoxia-induced neurodegeneration in the developing brain. Eighteen Wistar rat pups were divided into three groups: control group, hyperoxia+phosphate buffered saline treated group and hyperoxia+topiramate treated group. Hyperoxia groups were exposed to 80% oxygen (n=12) in plexiglas chambers in which the oxygen concentration was monitored twice daily from birth until postnatal day five. The hyperoxia+topiramate group received an intraperitoneal injection of topiramate at a dose of 80 mg/kg/day. At postnatal day 5, all animals were killed. Neuronal cell death and apoptosis were evaluated. Histopathological examination showed that topiramate significantly diminished apoptosis in the CA1 region and dentate gyrus of hippocampus. Topiramate may offer a therapeutic potential for neuroprotection under conditions of hyperoxic brain injury.